In the case of PCa, although different prognostic factors for disease progression and mortality have been established including Gleason score, clinical stage, prostate-specific antigen (PSA), presence of visceral or liver metastases, and number of metastatic sites [11], there is a lack of a clear conclusion or consensus about the prognosis role of sarcopenia. The gene discussed is KLK3; the disease is sarcopenia.